ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Hexagon Nutrition Ltd has scheduled a Board Meeting for September 30, 2026, to discuss requisition letters for appointing directors and approving remuneration.
Hexagon Nutrition Limited announced the appointment of an Executive Director, re-appointment of a Joint Managing Director, and the appointment of a Secretarial Auditor.
Hexagon Nutrition informed exchanges that its promoters abstained from voting on certain resolutions. The company is currently seeking independent legal advice regarding this matter.
Hexagon Nutrition Limited held its 33rd Annual General Meeting on September 22, 2026. The meeting transacted business as listed in the AGM notice.
Promoters and promoter group members of Hexagon Nutrition Ltd purchased 40,000 equity shares via open market transactions, with a total consideration of ₹0.26 Crore.
Dr. Nikhil Kelkar, promoter and joint MD of Hexagon Nutrition, acquired 10,000 equity shares in the open market. His stake rose from 17.27% to 17.28%.
Hexagon Nutrition Limited has intimated the stock exchanges regarding the dispatch of a communication providing a web-link for the 33rd Annual General Meeting and Annual Report.
Hexagon Nutrition received a Customs order demanding payment of Rs. 1.05 Crore, including duty and penalties. The Company intends to file an appeal against the findings.
Hexagon Nutrition Ltd has scheduled its 33rd Annual General Meeting for September 22, 2026, and released the Annual Report for the Financial Year 2025-26.
Hexagon Nutrition delivered strong Q1 FY27 results with 43.2% revenue growth and 25.1% PAT growth. Management focused on expanding the branded portfolio and optimizing capacity utilization.
Anuradha Arun Kelkar, a promoter group member of Hexagon Nutrition Ltd, acquired 15,000 equity shares via open market. This transaction increased her stake from 7.37% to 7.38%.
Hexagon Nutrition reported Q1 FY27 revenue of ₹1,043 Mn with 11.3% EBITDA margin. The firm focuses on specialized clinical and wellness nutrition brands like Pentasure and Pediagold.
Hexagon Nutrition reported Q1 FY27 revenue of ₹104.3 crore, a 43.2% YoY growth. Profit after tax rose 25.1% to ₹8.1 crore.
Hexagon Nutrition announced the appointment of Mr. Raghunath Sawant and re-appointment of Mr. Arun Purushottam Kelkar as Executive Directors for a five-year term.
Hexagon Nutrition Limited has appointed Mr. Raghunath Sawant as Executive Director and re-appointed Mr. Arun Purushottam Kelkar as Executive Director.
Hexagon Nutrition Limited has issued the notice for its 33rd Annual General Meeting scheduled for September 22, 2026. The meeting agenda includes dividend declaration and director appointments.
Hexagon Nutrition Limited board approved a final dividend of ₹0.30 per equity share for the financial year 2025-2026. The record date is September 15, 2026.
Hexagon Nutrition Ltd reported revenue from operations of ₹104.3 Cr (+43.1% YoY) and net profit of ₹8.1 Cr (+24.6% YoY) for Q1 FY27.